Inhibace submite 1 mg
Inhibace submite 1 mg is a medicine authorised by Swissmedic under authorisation number 50373. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 February 1990 and the authorisation is valid without a time limit. ATC code C09AA08 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 50373 |
|---|---|
| Name | Inhibace submite 1 mg |
| Full name | Inhibace submite 1 mg, Filmtabletten |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09AA08 |
| First authorisation | 21 February 1990 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Inhibace submite 1 mg, Filmtabletten | B | 21 February 1990 |
| 3 | Inhibace mite 2,5 mg, Filmtabletten | B | 21 February 1990 |
| 5 | Inhibace 5 mg, Filmtabletten | B | 26 July 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 29 | 30 | Tablette(n) | C09AA08 | 02.07.1. | B |
| 37 | 28 | Tablette(n) | C09AA08 | 02.07.1. | B |
| 142 | 100 | Tablette(n) | C09AA08 | 02.07.1. | B |
| 88 | 28 | Tablette(n) | C09AA08 | 02.07.1. | B |
| 150 | 100 | Tablette(n) | C09AA08 | 02.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Inhibace submite 1 mg authorised in Switzerland?
Yes. Inhibace submite 1 mg is authorised by Swissmedic under authorisation number 50373, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Inhibace submite 1 mg have?
Inhibace submite 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Inhibace submite 1 mg?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.